Leadership Overview
OraSure Technologies has 4 executives leading key functions including corporate strategy, financial oversight, and operational management.
Focused on global health accessibility, OraSure Technologies delivers essential diagnostic information to improve wellness outcomes through advanced research and development initiatives across international markets.
Focused on global health accessibility, OraSure Technologies delivers essential diagnostic information to improve wellness outcomes through advanced research and development initiatives across international markets.
Leadership Roles at OraSure Technologies
Rick Wood - President & Chief Executive Officer & Owner
Rick Wood, the President & Chief Executive Officer & Owner at OraSure Technologies, directs the overarching corporate vision and long-term ownership strategy. Wood architects the expansion of diagnostic health solutions, ensuring the company maintains a competitive edge in global wellness markets. By aligning internal research capabilities with external market demands, the President & Chief Executive Officer & Owner secures sustainable growth and operational excellence. Rick Wood manages high-level stakeholder relationships, fostering innovation across the entire product portfolio. This leadership role involves constant evaluation of market trends to refine the delivery of essential health information. Through rigorous oversight of organizational assets, the President & Chief Executive Officer & Owner drives the company toward achieving its mission of improving global health outcomes. Wood maintains a focus on scalability, ensuring that diagnostic tools reach diverse populations effectively while upholding the highest standards of accuracy and reliability in every service provided.
Carrie Manner - President & Chief Executive Officer
Carrie Manner, the President & Chief Executive Officer at OraSure Technologies, executes the daily operational strategy and drives the company mission of providing accessible health information. Manner oversees the integration of diagnostic technologies into global healthcare systems, ensuring that products meet the needs of diverse medical environments. By coordinating cross-functional teams, the President & Chief Executive Officer optimizes internal processes to enhance service delivery and operational efficiency. Carrie Manner leads the implementation of strategic initiatives that expand the company footprint across international regions, focusing on market penetration and brand authority. This leadership role requires constant collaboration with the board to align business objectives with long-term financial health. Through the management of core business units, the President & Chief Executive Officer ensures that every diagnostic solution remains accurate and impactful. Manner prioritizes the development of innovative health tools, consistently pushing the boundaries of current research and development capabilities to improve wellness outcomes worldwide.
Kenneth McGrath - Chief Financial Officer
Kenneth McGrath, the Chief Financial Officer at OraSure Technologies, manages the fiscal health and capital allocation strategies necessary for supporting global diagnostic research. McGrath directs the financial planning and analysis departments, ensuring that resources align with the company mission of improving health and wellness. By overseeing budgetary controls and investment in research and development, the Chief Financial Officer secures the capital required for long-term innovation. Kenneth McGrath monitors market performance across North American and international operations, providing the data-driven insights needed for strategic decision-making. This leadership role involves maintaining rigorous compliance standards and transparent reporting to stakeholders. Through the optimization of financial structures, the Chief Financial Officer supports the expansion of diagnostic services into new markets. McGrath drives efficiency by identifying cost-saving opportunities without compromising the quality of essential health information, ultimately ensuring that the company remains financially resilient while pursuing its goal of providing accurate wellness data to the public.
Robert Mcmahon - Agilent Technologies Senior VP & Chief Financial Officer
Robert Mcmahon, the Agilent Technologies Senior VP & Chief Financial Officer at OraSure Technologies, architects the financial framework for large-scale diagnostic infrastructure and global supply chain logistics. Mcmahon oversees the integration of complex financial systems, ensuring that the company maintains the liquidity required for rapid technological advancement. By managing capital expenditures and risk assessment protocols, the Agilent Technologies Senior VP & Chief Financial Officer protects the company assets while facilitating growth in competitive health sectors. Robert Mcmahon collaborates with executive leadership to refine the fiscal strategy, focusing on maximizing shareholder value through disciplined investment in research and development. This leadership role involves analyzing global economic shifts to adjust operational spending, ensuring that the company remains agile in diverse markets. Through the implementation of robust financial controls, the Agilent Technologies Senior VP & Chief Financial Officer drives sustainable profitability, enabling the organization to continue providing essential health information to a global audience.
Explore Leadership Teams in Business Services
AXISCADES is a leading product engineering solutions company catering to the futuristic needs of aerospace, defence, heavy engineering, automotive, energy, medical & healthcare sectors. Headquartered in Bengalore
Company Leadership PS

DK
RJ
Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the United States, China and other countries
Company Leadership ZL
DK
AM
MW
KEMRI is a State Corporation established in Kenya in 1979, dedicated to conducting research in human health. It operates multiple specialized research centers focusing on various health-related fields, including infectious diseases, public health, and biotechnology. The institute aims to improve human health and quality of life through research, capacity building, and innovation, serving clients that include government bodies, healthcare providers, and international research organizations. KEMRI is recognized as a leading center of excellence in health research both regionally and globally.
Company Leadership JG
AO
AA
Ascential Technologies delivers design, development and manufacturing solutions that tackle the toughest problems, unlocking performance for mission-critical companies. With global scale, deep expertise and practical know-how born from seven decades on the cutting edge of automation, Ascential partners with customers every step of the way to accelerate and realize their innovations. We deliver a range of offerings, from the most complex diagnostic tools used in life sciences, to the development and testing of adaptive safety systems in electric vehicles, to the inspection of advanced microprocessors for functional integrity and much more. Through our diverse portfolio of solutions, Ascential helps customers accelerate their innovation, mitigate risk, drive competitive differentiation, and reduce time to market at scale.
Company Leadership

GD